Sevoflurane, Propofol, Postoperative Pain
Postoperative Pain After Propofol Sevoflurane Anaesthesia: a Prospective, Randomized, Single-blinded Trial
1 other identifier
interventional
168
1 country
1
Brief Summary
The impact of anaesthetic method (intravenous vs. inhalational) has been proposed, but not proven in a large-scale study. The researchers aim to provide an investigation that has sufficient power to clarify the potential effect of anaesthetic method on postoperative need of opioids. Sevoflurane and propofol will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Oct 2008
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 19, 2011
CompletedFirst Posted
Study publicly available on registry
September 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedApril 10, 2013
April 1, 2013
4.4 years
September 19, 2011
April 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative consumption of an opioid (oxycodone)
The consumption of oxycodone will be monitored by recording the amount of the drug received via a commercially available patient controlled analgesia (PCA) pump.
20 hours
Secondary Outcomes (1)
NRS (numeral rating scale) of pain
20 hours
Interventions
Sevoflurane inhalation anesthesia, sufficient amount to maintain adequate general anesthesia for surgery
Propofol intravenous anesthesia, sufficient amount to maintain adequate anesthesia during surgery
Eligibility Criteria
You may qualify if:
- Age 18-69 years
- Gender: female
- ASA status 1-3
- Laparoscopic hysterectomy
You may not qualify if:
- Body Mass Index over 35
- Diabetes mellitus
- Liver disease
- Allergies to pharmaceuticals used in the Study
- Present use of opioids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampere University Hospital
Tampere, 33521, Finland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 19, 2011
First Posted
September 21, 2011
Study Start
October 1, 2008
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
April 10, 2013
Record last verified: 2013-04